These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31607860)

  • 1. CB
    González de San Román E; Manuel I; Ledent C; Chun J; Rodríguez de Fonseca F; Estivill-Torrús G; Santín LJ; Rodríguez Puertas R
    Front Mol Neurosci; 2019; 12():223. PubMed ID: 31607860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.
    González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R
    J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    González de San Román E; Llorente-Ovejero A; Martínez-Gardeazabal J; Moreno-Rodríguez M; Giménez-Llort L; Manuel I; Rodríguez-Puertas R
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the LPA
    Tabbai S; Moreno-Fernández RD; Zambrana-Infantes E; Nieto-Quero A; Chun J; García-Fernández M; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Oliveira TG; Pérez-Martín M; Pedraza C
    Front Mol Neurosci; 2019; 12():146. PubMed ID: 31244601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic Acid and Glutamatergic Transmission.
    Roza C; Campos-Sandoval JA; Gómez-García MC; Peñalver A; Márquez J
    Front Mol Neurosci; 2019; 12():138. PubMed ID: 31191247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid and its receptor LPA
    Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
    Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both genetic deletion and pharmacological blockade of lysophosphatidic acid LPA1 receptor results in increased alcohol consumption.
    Castilla-Ortega E; Pavón FJ; Sánchez-Marín L; Estivill-Torrús G; Pedraza C; Blanco E; Suárez J; Santín L; Rodríguez de Fonseca F; Serrano A
    Neuropharmacology; 2016 Apr; 103():92-103. PubMed ID: 26700247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex.
    García-Díaz B; Riquelme R; Varela-Nieto I; Jiménez AJ; de Diego I; Gómez-Conde AI; Matas-Rico E; Aguirre JÁ; Chun J; Pedraza C; Santín LJ; Fernández O; Rodríguez de Fonseca F; Estivill-Torrús G
    Brain Struct Funct; 2015 Nov; 220(6):3701-20. PubMed ID: 25226845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
    Olianas MC; Dedoni S; Onali P
    Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.
    Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y
    Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.
    Hopkins MM; Liu Z; Meier KE
    J Pharmacol Exp Ther; 2016 Oct; 359(1):124-33. PubMed ID: 27474750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear extinction and acute stress reactivity reveal a role of LPA(1) receptor in regulating emotional-like behaviors.
    Pedraza C; Sánchez-López J; Castilla-Ortega E; Rosell-Valle C; Zambrana-Infantes E; García-Fernández M; Rodriguez de Fonseca F; Chun J; Santín LJ; Estivill-Torrús G
    Brain Struct Funct; 2014 Sep; 219(5):1659-72. PubMed ID: 23775489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
    Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPA
    Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
    FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization.
    Funke M; Knudsen L; Lagares D; Ebener S; Probst CK; Fontaine BA; Franklin A; Kellner M; Kühnel M; Matthieu S; Grothausmann R; Chun J; Roberts JD; Ochs M; Tager AM
    Am J Respir Cell Mol Biol; 2016 Jul; 55(1):105-16. PubMed ID: 27082727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPA
    Olianas MC; Dedoni S; Onali P
    J Neurochem; 2017 Oct; 143(2):183-197. PubMed ID: 28815598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaminase and MMP-9 Downregulation in Cortex and Hippocampus of LPA
    Peñalver A; Campos-Sandoval JA; Blanco E; Cardona C; Castilla L; Martín-Rufián M; Estivill-Torrús G; Sánchez-Varo R; Alonso FJ; Pérez-Hernández M; Colado MI; Gutiérrez A; de Fonseca FR; Márquez J
    Front Mol Neurosci; 2017; 10():278. PubMed ID: 28928633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid stimulates astrocyte proliferation through LPA1.
    Shano S; Moriyama R; Chun J; Fukushima N
    Neurochem Int; 2008 Jan; 52(1-2):216-20. PubMed ID: 17692995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway.
    Zhang J; Li Y; Wang C; Wang Y; Zhang Y; Huang L; Zhang Z
    Front Mol Neurosci; 2020; 13():16. PubMed ID: 32116549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.